School of Medicine
Showing 81-100 of 215 Results
-
Tina Hernandez-Boussard
Professor of Medicine (Computational Medicine), of Biomedical Data Science, of Surgery and, by courtesy, of Epidemiology and Population Health
Current Research and Scholarly InterestsMy background and expertise is in the field of computational biology, with concentration in health services research. A key focus of my research is to apply novel methods and tools to large clinical datasets for hypothesis generation, comparative effectiveness research, and the evaluation of quality healthcare delivery. My research involves managing and manipulating big data, which range from administrative claims data to electronic health records, and applying novel biostatistical techniques to innovatively assess clinical and policy related research questions at the population level. This research enables us to create formal, statistically rigid, evaluations of healthcare data using unique combinations of large datasets.
-
David Ian Hindin
Clinical Assistant Professor, Surgery - General Surgery
BioDr. Hindin obtained his MD from the University of Pennsylvania Perelman School of Medicine in Philadelphia, Pennsylvania. He completed his general surgery training at Temple University School of Medicine, also in Philadelphia, and subsequently completed fellowship in surgical critical care at Stanford University School of Medicine. Dr. Hindin is currently the Associate Chair of Innovation at Stanford University’s Department of Surgery. He is also a Clinical Assistant Professor of Surgery at Stanford University in the section of Trauma and Critical Care Surgery and at the VA Palo Alto. Dr. Hindin additionally serves as Associate Director of Stanford University’s Biodesign Faculty Fellowship, a university-wide program that trains faculty members from medicine, engineering, and other schools in the process of creating health technology innovation, from needs-finding to commercialization.
Dr. Hindin has a particular interest in training physicians to leverage story-based skills to increase the effectiveness of their communication. He has previously developed and taught a semester-long storytelling course at Stanford Biodesign, which trains physicians and engineers to create more effective pitches when seeking venture funding. -
Filza Hussain MD, FACLP
Clinical Associate Professor, Psychiatry and Behavioral Sciences - Medical Psychiatry
Clinical Associate Professor (By courtesy), Surgery - Abdominal TransplantationBioDr. Filza Hussain completed her medical education at Aga Khan University in Karachi, Pakistan, and pursued psychiatry training at the Mayo Clinic in Rochester, Minnesota, where she was awarded the MJ Martin Award for Excellence in Consultation-Liaison Psychiatry and served as Chief Resident. She completed her fellowship in Consultation-Liaison Psychiatry at Columbia University in New York City and is a Fellow of the Academy of Consultation-Liaison Psychiatry.
Before joining Stanford, she served rural communities across eleven counties in Northwest Wisconsin as the sole outpatient psychiatric provider for a Mayo Clinic satellite practice, while also serving on the board of the National Alliance on Mental Illness and teaching psychopathology as part of Crisis Intervention Training for local law enforcement.
Dr. Hussain joined Stanford University School of Medicine in 2017. She serves as Lead Psychiatrist for the Liver and Kidney Transplant Programs at Stanford Health Care and holds a courtesy appointment in Abdominal Transplant Surgery. Her clinical work centers on expanding access to transplantation for patients with alcohol-associated liver disease. She contributed to the Stanford Limited Sobriety Pathway and led the development of FRAME-ALD (Fair and Risk-Aligned Model for Evaluation in Alcohol-Associated Liver Disease), a psychosocial risk stratification protocol now in active implementation at Stanford Health Care, built on the principle that all patients with alcohol-associated liver disease deserve individualized, evidence-based evaluation.
She developed the Immersion Series, an award-winning program bringing specialists from across medicine and surgery to teach Consultation-Liaison Psychiatry fellows, and served as Chair of the Education Committee and Associate Program Director of the fellowship, during which time she grew the program from two to four fellows and helped establish a Psycho-Oncology training track.
Her scholarly work spans transplant psychiatry, substance use in solid organ transplantation, and medical education. She has presented at national and international meetings and contributed chapters to major texts in transplant psychiatry and neuropsychiatry.
Dr. Hussain's interests include the role of psychiatric care in promoting equity in transplantation and the relationship between physician identity, wellbeing, and patient care. -
Joo Ha Hwang, MD, PhD
Fortinet Founders School of Medicine Professor and Professor, by courtesy, of Surgery
Current Research and Scholarly InterestsSpecialize in early detection of gastrointestinal malignancies including esophageal, gastric, pancreatic, bile duct & colon cancers. I have both a clinical & research interest in improving the early detection of gastric cancer in particular. I am the PI of the Gastric Precancerous conditions Study, a prospective study of patients with gastric intestinal metaplasia & other precancerous conditions which combines comprehensive clinical & endoscopic data with a large bio-specimen repository.
-
Ahmer Irfan, MD
Clinical Assistant Professor, Surgery - General Surgery
BioDr. Ahmer Irfan is a board-certified, fellowship-trained hepatobiliary surgeon with Stanford Health Care. He is also a clinical assistant professor in the Department of Surgery, Division of General Surgery at Stanford University School of Medicine.
Dr. Irfan cares for cancer affecting the liver, pancreas, biliary system, and gastrointestinal system, often treating complex and advanced cancers. He specializes in performing minimally invasive surgery to remove cancer using laparoscopic, robotic, and ablative techniques. He takes a compassionate approach to cancer care, working with patients and families to develop personalized treatment plans that align with their goals.
Dr. Irfan’s research focuses on improving outcomes for patients with liver, pancreatic, and gastrointestinal cancers through advances in surgical care. His work has explored how surgeons make treatment decisions and how health care systems can optimize patient support throughout the cancer journey. He has also studied the use of advanced surgical techniques, including robotic surgery and vascular reconstruction, to treat complex cancers safely.
Dr. Irfan has published his findings in leading peer-reviewed journals, including the International Journal of Cancer, Journal of the American College of Surgeons, and HPB. He has also shared his research and expertise at prestigious surgical meetings of the Americas Hepato-Pancreato-Biliary Association (AHPBA), International Hepato-Pancreato-Biliary Association (IHPBA), and Pancreas Club. His presentation topics have focused on innovations in hepato-pancreato-biliary surgery, complex cancer care, and surgical education.
Dr. Irfan is a member of AHPBA, IHPBA, and Royal College of Physicians and Surgeons of Glasgow (RCPSG). -
Stefanie S. Jeffrey, MD
John and Marva Warnock Professor, Emerita
Current Research and Scholarly InterestsDr. Jeffrey led the multidisciplinary team from the Schools of Medicine, Engineering, and Genome Technology Center that invented the MagSweeper, an automated device that immunomagnetically captures live circulating tumor cells (CTCs) from cancer patient blood for single cell analysis or culture. Her lab also works on microfluidic technologies for tumor cell capture, characterization, and growth - with the goal of defining individual patient response to newer biologically-based cancer therapies.
-
David Kahn, M.D.
Current Research and Scholarly InterestsCosmetic surgery and the study of changes associated with the aging appearance of the face.
1. Analysis and development of new procedures for aesthetic surgery of the face
2. Analysis of the changes the face undergoes with age in the bone and soft tissues
3. Analysis of techniques for rhinoplasty
4. Evaluation of optimal techniques for aesthetic and reconstructive breast surgery -
Nathan Kalinowski, D.M.D.
Clinical Assistant Professor, Surgery - Plastic & Reconstructive Surgery
BioDr. Nathan Kalinowski is a Hospital Dentist and Clinical Assistant Professor in Dental Medicine and Surgery. He performs medically necessary dental clearance and extractions for patients preparing for cardiac surgery, radiation therapy, or organ transplantation. He also performs surgical treatment of infection and trauma to the teeth and supporting alveolar bone including reconstruction using dental implants.
-
Robin Kamal MD MBA
Associate Professor of Orthopaedic Surgery and, by courtesy, of Surgery (Plastic and Reconstructive Surgery)
Current Research and Scholarly InterestsWrist and Elbow Injuries and Quality Measures in Orthopaedic Surgery
-
Mardi Karin, MD, FACS
Clinical Professor, Surgery - General Surgery
BioDr. Mardi R. Karin is a board certified surgeon with over 20 years of experience, specializing in breast surgery and is Clinical Professor of Surgery in Stanford University Department of Surgery, Section of Surgical Oncology. She was appointed the first Clinical Director of Breast Cancer Care at Stanford Cancer Center South Bay after the new cancer center opened and served in this role from 2016-2019. Dr. Karin specializes in the surgical treatment of breast diseases and cancer. In addition to providing outstanding care, her focus and leadership in breast cancer care includes improving coordinated care for breast cancer treatment both within the Cancer Center and the community.
Dr. Karin has extensive experience in breast surgery, including complex breast cancer skin and nipple sparing procedures in coordination with the plastic surgeon for immediate breast reconstruction and optimal appearance with excellent outcomes. She collaborates closely with Plastic and Reconstructive Surgery to provide the best options to patients, including Oncoplastics for optimal aesthetic appearance with breast conservation treatment, in addition to mastectomy with nipple sparing and immediate breast reconstruction. Her clinical research is focused on improving patient outcomes in different aspects of breast surgery, including nipple sparing mastectomy by utilizing MRI blood flow information to preserve important blood flow to reduce complications. She also is involved with advancing surgical techniques to decrease lymphedema rates after axillary lymph node dissection, with lymphatic preservation and possible LYMPHA procedure by the Plastic Reconstructive Microsurgeons. In addition, she works in close collaboration with Medical Oncology to offer the latest most advanced treatments for breast cancer. -
Karthikeshwar Kasirajan (Kasi)
Clinical Professor, Surgery - Vascular Surgery
BioDr. Kasirajan is a board-certified, fellowship-trained vascular surgeon. Also known as Dr. Kasi, he is a clinical professor of vascular surgery at Stanford University School of Medicine.
Dr. Kasirajan preserves limbs, facilitates access to dialysis, and helps his patients manage conditions such as aneurysms, varicose veins, thoracic outlet syndrome, and deep vein thrombosis. Many of his limb preservation patients smoke, have diabetes, or are experiencing renal failure. Dr. Kasirajan’s experience also centers around the treatment of aneurysms and prevention of strokes.
In all cases, his goal is to provide either noninvasive or minimally invasive management whenever possible. He performs open surgery only when it is the best option. Dr. Kasirajan treats many patients with stents and stent grafts, which can shorten hospital stays and recovery times.
Dr. Kasirajan (Kasi) receives referrals of patients from primary care physicians, nephrologists, podiatrists, cardiologists, woundcare specialists, diabetologists, neurologists, and other specialists. He welcomes referrals as early as possible, ideally before patients become symptomatic. A strong proponent of doing early screening for peripheral artery disease, Dr. Kasirajan advocates for the use of the ankle-brachial index (ABI) in routine physical examinations. When providers detect an imbalance between leg and arm blood pressure, Dr. Kasirajan can help create customized strategies to address the cause before the problem worsens.
In addition to offering excellent vascular care to the community, Dr. Kasirajan joined Stanford to continue pursuing his research interests. He has conducted research into advances in minimally invasive procedures for stroke prevention and for aneurysm management. His research has also focused on how to improve surgery outcomes to help patients suffering from peripheral vascular disease. Dr. Kasirajan has been the investigator in over 40 multicenter studies involving new stent graphs, thrombectomy catheters, and other advances in endovascular technology.
Dr. Kasirajan has made more than 100 presentations worldwide on minimally invasive vascular surgery techniques and preventive care in the vascular patient. He has spoken at multiple conferences including the Society for Vascular Surgery, Peripheral Vascular Society, and the South Asian American Vascular Society. He has earned numerous honors for his academic achievements, including the prestigious Alpha Omega Alpha award for medical student and resident education.
As the author of more than 120 journal articles, Dr. Kasirajan’s work has appeared in the Journal of Vascular Surgery, Endovascular Today, Pharmacogenomics Journal, Catheter Cardiovascular Intervention, and many other publications. He also has authored 20 book chapters in textbooks including Medical Management of the Surgical Patient 5th Edition, Advances in Phlebology and Venus Surgery Volume 1, Current Therapy in Vascular Surgery, Mastery of Surgery, and many more.
Dr. Kasirajan has served on the editorial boards of the Journal of Endovascular Therapy, Annals of Vascular Surgery, International Journal of Angiology, and other publications. -
David Kauvar
Clinical Professor, Surgery - Vascular Surgery
BioDavid Kauvar, MD, MPH is an academic vascular surgeon who received his undergraduate medical education on active duty in the US Army at the Uniformed Services University of the Health Sciences in Bethesda, Maryland. He completed his residency in general surgery at Brooke Army Medical Center in San Antonio, Texas, a surgical research fellowship at the United States Army Institute for Surgical Research, and a clinical fellowship at the University of Utah. His 24-year career as a wartime and vascular surgeon culminated with his retirement in 2022. During his tenure in the military, Dr. Kauvar was a respected surgical educator and became an academic leader in the fields of military and vascular trauma. He earned a Master of Public Health degree from the University of North Texas and was inducted into the Order of Military Medical Merit for his contributions to military medicine.
Dr. Kauvar has served as a general surgery residency associate program director for research and as a residency program director, chair of an institutional review board, and chief of a vascular surgery service. He commanded a combat surgical unit in Afghanistan and led two multimillion-dollar Department of Defense combat casualty care research labs. He has authored over eighty peer-reviewed publications and numerous textbook chapters, has presented research at dozens of national and international surgical meetings and has been invited to speak internationally about vascular trauma as an acknowledged expert in the field.
Dr. Kauvar is now Clinical Professor of Surgery in the Division of Vascular Surgery at Stanford University School of Medicine with his primary clinical responsibilities at Santa Clara Valley Medical Center in San Jose, California. He is married and has one son. -
Electron Kebebew, MD, FACS
Harry A. Oberhelman, Jr. and Mark L. Welton Professor
Current Research and Scholarly InterestsDr. Kebebew’s translational and clinical investigations have three main scientific goals: 1) to develop effective therapies for fatal, rare and neglected endocrine cancers, 2) to identify new methods, strategies and technologies for improving the diagnosis and treatment of endocrine neoplasms and the prognostication of endocrine cancers, and 3) to develop methods for precision treatment of endocrine tumors.
